Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nope guess again dbag. Still own all my shares
Absolutely
100%
OTC Markets updated.
OBCN SECURITY DETAILS
Share Structure
Market Cap Market Cap
5,260,601 06/09/2021
Authorized Shares
800,000,000 06/08/2021
Outstanding Shares
42,803,915 06/08/2021
Agreed. Op is lost in space
Wow. Are you lost in space. Stan has been out of the picture for a long time.
Exactly. What a moron
That comment shows how stupid you are.
Not worried
Fixing and updating otc markets
Getting closer.
Someone only shows up when the price declines. Smh
Agreed
Progress being made with otcmarkets. Looking forward to seeing it corrected.
That’s complete bs
Not offended. You’re ridiculous
Why are you here? Come back when it’s over $1
Carry on
Yes
Nope. All good
Could see $10.50 too
550k
This ANALyst is a fool
LONG LARGE
They are also getting a new attorney to help speed up the process
If it was a scam, the ceo would have cashed out most of his shares. And director Junge (John) Zhang, PhD has not cashed out of a single share. And he is by far the largest independent shareholder with 1,215,000 shares
Are you new here??
I don't see the major holders that are actually tied to the company now selling
Learn to read filings:
"This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."
Rule 10b5-1
By ADAM HAYES Reviewed by MARGARET JAMES Updated Apr 24, 2021
What Is Rule 10b5-1?
Rule 10b5-1, established by the Securities and Exchange Commission (SEC) in 2000, allows insiders of publicly-traded corporations to set up a trading plan for selling stocks they own. It is a clarification of Rule 10b-5 (sometimes written as Rule 10b5), created under the Securities and Exchange Act of 1934, which is the primary vehicle for investigation of securities fraud.
Rule 10b5-1 permits major holders to sell a predetermined number of shares at a predetermined time. Many corporate executives use 10b5-1 plans to avoid accusations of insider trading.
KEY TAKEAWAYS
Rule 10b5-1 allows company insiders to set up a predetermined plan to sell company stocks in accordance with insider trading laws.
The price, amount, and sales dates must be specified in advance and determined by a formula or metrics.
Both the seller and the broker making the sales must not have access to any material nonpublic information (MNPI).
Understanding Rule 10b5-1
Rule 10b5-1 allows company insiders to make predetermined trades while following insider trading laws and avoiding insider trading accusations. It is recommended that companies permit an executive to either adopt or amend a 10b5-1 plan when its executives are allowed to trade the securities in tandem with their insider trading policy. Rule 10b5-1 stops any insiders from changing or adopting a plan if they are in possession of material nonpublic information (MNPI).
It is not uncommon to see a major shareholder sell some of their shares at regular intervals. A director of XYZ Corporation, for example, may choose to sell 5,000 shares of stock on the second Wednesday of every month. To avoid conflict, Rule 10b5-1 plans must be established when the individual is unaware of any MNPI. These plans usually exist as a contract between the insider and their broker.
Under Rule 10b5-1, directors and other major insiders in the company—large shareholders, officers, and others who have access to MNPI—can establish a written plan that details when they can buy or sell shares at a predetermined time on a scheduled basis. It is set up this way so that they are able to make these transactions when they are not in the vicinity of MNPI. This also allows companies to utilize 10b5-1 plans in large stock buybacks.
Requirements for Rule 10b5-1
For insiders to enter into a Rule 10b5-1 plan, they must not have any access to MNPI regarding anything about the company as well the company’s securities. To be valid, the plan must follow three distinct criteria:
The price and amount must be specified (this may include a set price) and certain dates of sales or purchases must be noted.
There must be a formula or metrics given for determining the amount, price, and date.
The plan must give the broker the exclusive right to determine when to make sales or purchases, as long as the broker does so without any MNPI when the trades are being made.
Special Considerations
There is nothing in the SEC laws that makes it necessary to disclose the use of Rule 10b5-1 to the public, but that doesn’t mean companies shouldn’t release the information anyway. Announcements of utilizing Rule 10b5-1 are useful in warding off public relations problems and helping investors understand the logistics behind certain insider trades.
He hasn't worked at the company in many years. It was a scheduled sell. No bearing on anything.
Of course it will. Unless you want to possibly get blood clots and other abnormalities with all the others
You missed the new fantastic news. Good to be short or not long. Hahahahahahaha
Agreed. Huge upside ahead.
You are incorrect
Genius.
You are clueless
Where do you think a majority of generic drugs are manufactured... India
Pathetic
100%. No stopping it now.
Yup lol